The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Open accessAbstract
Mesenchymal stromal cells (MSCs) as a pharmaceutical for ailments characterized by pathogenic autoimmune, alloimmune and inflammatory processes now cover the spectrum of early- to late-phase clinical trials in both industry and academic sponsored studies. There is a broad consensus that despite different tissue sourcing and varied culture expansion protocols, human MSC-like cell products likely share fundamental mechanisms of action mediating their anti-inflammatory and tissue repair functionalities. Identification of functional markers of potency and reduction to practice of standardized, easily deployable methods of measurements of such would benefit the field. This would satisfy both mechanistic research as well as development of release potency assays to meet Regulatory Authority requirements for conduct of advanced clinical studies and their eventual registration. In response to this unmet need, the International Society for Cellular Therapy (ISCT) addressed the issue at an international workshop in May 2015 as part of the 21st ISCT annual meeting in Las Vegas. The scope of the workshop was focused on discussing potency assays germane to immunomodulation by MSC-like products in clinical indications targeting immune disorders. We here provide consensus perspective arising from this forum. We propose that focused analysis of selected MSC markers robustly deployed by in vitro licensing and metricized with a matrix of assays should be responsive to requirements from Regulatory Authorities. Workshop participants identified three preferred analytic methods that could inform a matrix assay approach: quantitative RNA analysis of selected gene products; flow cytometry analysis of functionally relevant surface markers and protein-based assay of secretome. We also advocate that potency assays acceptable to the Regulatory Authorities be rendered publicly accessible in an "open-access" manner, such as through publication or database collection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Self-citationPlasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452
Self-citationCXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance
Greenbaum, A., Hsu, Y.-M. S., Day, R. B., Schuettpelz, L. G., Christopher, M. J., Borgerding, J. N., Nagasawa, T., & Link, D. C. (2013) · Nature · doi:10.1038/nature11926 · Cited by 1,371
Ortiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019
Self-citationFrançois, M., Romieu-Mourez, R., Li, M., & Galipeau, J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.189 · Cited by 694
Self-citationRen, G., Zhao, X., Zhang, L., Zhang, J., L'Huillier, A., Ling, W., Roberts, A. I., Le, A. D., Shi, S., Shao, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902023 · Cited by 656
Self-citationKeating, A. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000245697.54887.6f · Cited by 626
Ries, C., Egea, V., Karow, M., Kolb, H., Jochum, M., & Neth, P. (2007) · Blood · doi:10.1182/blood-2006-10-051060 · Cited by 539
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
Mendicino, M., Bailey, A. M., Wonnacott, K., Puri, R. K., & Bauer, S. R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.013 · Cited by 497
Self-citationA20 in inflammation and autoimmunity
Catrysse, L., Vereecke, L., Beyaert, R., & van Loo, G. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.005 · Cited by 493
Krampera, M., Galipeau, J., Shi, Y., Tarte, K., & Sensebe, L. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.02.010 · Cited by 464
Self-citationKebriaei, P., Isola, L., Bahceci, E., Holland, K., Rowley, S., McGuirk, J., Devetten, M., Jansen, J., Herzig, R., Schuster, M., et al. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.03.012 · Cited by 437
Bai, L., Lennon, D. P., Caplan, A. I., DeChant, A., Hecker, J., Kranso, J., Zaremba, A., & Miller, R. H. (2012) · Nature Neuroscience · doi:10.1038/nn.3109 · Cited by 421
François, M., Copland, I. B., Yuan, S., Romieu-Mourez, R., Waller, E. K., & Galipeau, J. (2012) · Cytotherapy · doi:10.3109/14653249.2011.623691 · Cited by 375
Self-citationRinge, J., Strassburg, S., Neumann, K., Endres, M., Notter, M., Burmester, G., Kaps, C., & Sittinger, M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21172 · Cited by 371
Mesenchymal stromal cell ‘licensing’: a multistep process
Krampera, M. (2011) · Leukemia · doi:10.1038/leu.2011.108 · Cited by 358
Self-citationHung, S.-C., Pochampally, R. R., Hsu, S.-C., Sanchez, C., Chen, S.-C., Spees, J., & Prockop, D. J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000416 · Cited by 317
Romieu-Mourez, R., François, M., Boivin, M.-N., Bouchentouf, M., Spaner, D. E., & Galipeau, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803864 · Cited by 299
Self-citationMonocyte Chemotactic Protein-3 Is a Myocardial Mesenchymal Stem Cell Homing Factor
Schenk, S., Mal, N., Finan, A., Zhang, M., Kiedrowski, M., Popovic, Z., McCarthy, P. M., & Penn, M. S. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0293 · Cited by 274
Chinnadurai, R., Copland, I. B., Patel, S. R., & Galipeau, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301828 · Cited by 266
Self-citationHuman multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
Gieseke, F., Böhringer, J., Bussolari, R., Dominici, M., Handgretinger, R., & Müller, I. (2010) · Blood · doi:10.1182/blood-2010-02-270777 · Cited by 265
Self-citationQi, Y., Jiang, D., Sindrilaru, A., Stegemann, A., Schatz, S., Treiber, N., Rojewski, M., Schrezenmeier, H., Vander Beken, S., Wlaschek, M., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.328 · Cited by 245
Rafei, M., Hsieh, J., Fortier, S., Li, M., Yuan, S., Birman, E., Forner, K., Boivin, M.-N., Doody, K., Tremblay, M., et al. (2008) · Blood · doi:10.1182/blood-2008-07-166892 · Cited by 224
Self-citationBrooke, G., Tong, H., Levesque, J.-P., & Atkinson, K. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0156 · Cited by 213
Menard, C., Pacelli, L., Bassi, G., Dulong, J., Bifari, F., Bezier, I., Zanoncello, J., Ricciardi, M., Latour, M., Bourin, P., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0594 · Cited by 197
Self-citationHall, S. R. R., Tsoyi, K., Ith, B., Padera, R. F., Lederer, J. A., Wang, Z., Liu, X., & Perrella, M. A. (2013) · Stem Cells · doi:10.1002/stem.1270 · Cited by 192
Mesenchymal stem cells are injured by complement after their contact with serum
Li, Y., & Lin, F. (2012) · Blood · doi:10.1182/blood-2012-03-420612 · Cited by 167
Bladergroen, B. A., Meijer, C. J. L. M., ten Berge, R. L., Hack, C. E., Muris, J. J. F., Dukers, D. F., Chott, A., Kazama, Y., Oudejans, J. J., van Berkum, O., et al. (2002) · Blood · doi:10.1182/blood.v99.1.232 · Cited by 162
Egea, V., Zahler, S., Rieth, N., Neth, P., Popp, T., Kehe, K., Jochum, M., & Ries, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115083109 · Cited by 151
Viswanathan, S., Keating, A., Deans, R., Hematti, P., Prockop, D. J., Stroncek, D. F., Stacey, G., Weiss, D. J., Mason, C., & Rao, M. S. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0591 · Cited by 137
Self-citationYoo, S., Chang, D., Lee, H. S., Kim, G., Park, J., Ryu, B., Joe, E.-H., Lee, Y., Kim, S., & Suh‐Kim, H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.001 · Cited by 126
Croitoru‐Lamoury, J., Lamoury, F. M. J., Zaunders, J., Veas, L. A., & Brew, B. J. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.0037 · Cited by 115
Chamberlain, G., Smith, H. K., Rainger, G. E., & Middleton, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025663 · Cited by 110
Wei, F., Leung, K., Li, G., Qin, J., Chow, S. K., Huang, S., Sun, M.-H., Qin, L., & Cheung, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106722 · Cited by 107
TLR Ligands Stimulation Protects MSC from NK Killing
Giuliani, M., Griscelli, A. B., Nanbakhsh, A., Oudrhiri, N., Chouaïb, S., Azzarone, B. G., Dürrbach, A., & Lataillade, J.-J. (2013) · Stem Cells · doi:10.1002/stem.1563 · Cited by 103
Campeau, P. M., Rafei, M., Boivin, M., Sun, Y., Grabowski, G. A., & Galipeau, J. (2009) · Blood · doi:10.1182/blood-2009-02-205708 · Cited by 100
Self-citationHuman mesenchymal stem cells as a stable source of VEGF-producing cells
Kagiwada, H., Yashiki, T., Ohshima, A., Tadokoro, M., Nagaya, N., & Ohgushi, H. (2008) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.79 · Cited by 78
Development of a surrogate angiogenic potency assay for clinical-grade stem cell production
Lehman, N., Cutrone, R., Raber, A., Perry, R., van't Hof, W., Deans, R., Ting, A. E., & Woda, J. (2012) · Cytotherapy · doi:10.3109/14653249.2012.688945 · Cited by 76 · cited 1×
“(Cleveland, OH) outlining their effort in establishing an angiogenic potency assay for their MultiStem product based on measure of CXCL5, interleukin (IL)-8 and vascular endothelial growth factor (VEGF) production coupled to an in vitro cell-based angiogenic assay [6].”
Self-citationGalipeau, J., & Krampera, M. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2014.12.008 · Cited by 75
Self-citationLi, H., Jiang, Y., Jiang, X., Guo, X., Ning, H., Li, Y., Liao, L., Yao, H., Wang, X., Liu, Y., et al. (2014) · Stem Cells · doi:10.1002/stem.1656 · Cited by 69
Naji, A., Rouas‐Freiss, N., Dürrbach, A., Carosella, E. D., Sensebé, L., & Deschaseaux, F. (2013) · Stem Cells · doi:10.1002/stem.1494 · Cited by 68
Chinnadurai, R., Copland, I. B., Ng, S., Garcia, M. A., Prasad, M., Arafat, D., Gibson, G. C., Kugathasan, S., & Galipeau, J. (2015) · Molecular Therapy · doi:10.1038/mt.2015.67 · Cited by 67
Self-citationMesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage
Soland, M. A., Bego, M. G., Colletti, E. J., Zanjani, E. D., Jeor, S. S., Porada, C. D., & Almeida-Porada, G. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060461 · Cited by 58
IFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway
Yang, X., Du, J., Xu, X., Xu, C., & Song, W. (2014) · Journal of Immunology Research · doi:10.1155/2014/318098 · Cited by 52
Phinney, D. G., Galipeau, J., Krampera, M., Martín, I., Shi, Y., & Sensebé, L. (2013) · Nature Medicine · doi:10.1038/nm.3220 · Cited by 48
Self-citationTang, K. C., Trzaska, K. A., Sv, S., Kotenko, S. V., Schwander, S., Ellner, J. J., & Rameshwar, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1826 · Cited by 47
Kimura, K., Nagano, M., Salazar, G. T., Yamashita, T., Tsuboi, I., Mishima, H., Matsushita, S., Sato, F., Yamagata, K., & Ohneda, O. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0307 · Cited by 41
Salem, B., Miner, S. A., Hensel, N. F., Battiwalla, M., Keyvanfar, K., Stroncek, D. F., Gee, A. P., Hanley, P. J., Bollard, C. M., Ito, S., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.08.008 · Cited by 39
Self-citationPodechard, N., Fardel, O., Corolleur, M., Bernard, M., & Lecureur, V. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.05.011 · Cited by 39
Functional RIG-I-like receptors control the survival of mesenchymal stem cells
Yang, K., Wang, J., Xiang, A. P., Zhan, X., Wang, Y., Wu, M., & Huang, X. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.504 · Cited by 39
Schweizer, R., Kamat, P., Schweizer, D., Dennler, C., Zhang, S., Schnider, J. T., Salemi, S., Giovanoli, P., Eberli, D., Enzmann, V., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.05.008 · Cited by 30
François, M., Birman, E., Forner, K.-A., Gaboury, L. A., & Galipeau, J. (2012) · Cytotherapy · doi:10.3109/14653249.2012.684378 · Cited by 26
Self-citationFeng, Y., Yu, H., Shang, D., Fang, W., He, Z.-Y., & Chen, Y. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1257-7 · Cited by 20
Towards the creation of a standard MSC line as a calibration tool
Deans, R. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.07.010 · Cited by 13
Self-citation
Cited by
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Self-citationMesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
“At best, potency assays mirror hypothesis-driven informed guesses that are in part cognizant of pre-clinical animal systems and in vitro cell biology(Galipeau et al., 2016).”
BackgroundSelf-citationViswanathan, S., Shi, Y., Galipeau, J., Krampera, M., Leblanc, K., Martin, I., Nolta, J., Phinney, D. G., & Sensebe, L. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.08.002 · Cited by 839
Self-citationMorrison, T. J., Jackson, M. V., Cunningham, E. K., Kissenpfennig, A., McAuley, D. F., O’Kane, C. M., & Krasnodembskaya, A. D. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0170oc · Cited by 796
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Metadata
- Authors
- Galipeau, J., Krampera, M., Barrett, J., Dazzi, F., Deans, R. J., DeBruijn, J., Dominici, M., Fibbe, W. E., Gee, A. P., Gimble, J. M., Hematti, P., Koh, M. B. C., LeBlanc, K., Martin, I., McNiece, I. K., Mendicino, M., Oh, S., Ortiz, L., Phinney, D. G., Planat, V., Shi, Y., Stroncek, D. F., Viswanathan, S., Weiss, D. J., & Sensebe, L.
- Venue
- Cytotherapy
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 18
- Issue
- 2
- Pages
- 151-159
- ISSN
- 1465-3249 (ISSN-L)
- OpenAlex
- W2201248084
- Cited by
- 520
- References
- 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.